S'abonner

Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels - 15/08/11

Doi : 10.1016/j.jaci.2008.11.018 
Patrizia Bonadonna, MD a, i, Omar Perbellini, MD b, i, Giovanni Passalacqua, MD c, , Beatrice Caruso, MD d, Sabrina Colarossi, BS e, i, Daniela Dal Fior, MD f, Luca Castellani, MD g, Chiara Bonetto, MSc h, Francesco Frattini, MD b, Annarita Dama, MD a, Giovanni Martinelli, MD e, i, Marco Chilosi, MD f, Gianenrico Senna, MD a, Giovanni Pizzolo, MD b, Roberta Zanotti, MD b, i
a Allergy Unit, Verona General Hospital, Verona, Italy 
b Department of Clinical and Experimental Medicine, Haematology Section, University of Verona, Verona, Italy 
c Allergy and Respiratory Diseases, DIMI, University of Genoa, Genoa, Italy 
d Clinical Chemistry and Haematology, Verona General Hospital, Verona, Italy 
e Department of Haematology/Oncology, L. and A. Seragnoli, University of Bologna, Bologna, Italy 
f Department of Pathology, University of Verona, Verona, Italy 
g Department of Dermatology, Santa Maria del Carmine Hospital, Rovereto, Italy 
h Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy 
i Rete Italiana Mastocitosi (RIMA), Bologna, Italy 

Reprint requests: Giovanni Passalacqua, MD, Allergy and Respiratory Diseases, Department of Internal Medicine, Padiglione Maragliano, L.go R. Benzi 10, 16132 Genoa, Italy.

Abstract

Background

Anaphylaxis after Hymenoptera stings has been reported in subjects with mastocytosis, but few data exist regarding disease prevalence in populations allergic to these insects.

Objective

The incidence of clonal mast cell (MC) disorders in subjects with both systemic reactions to Hymenoptera stings and increased serum baseline tryptase (sBT) levels was assessed by using bone marrow (BM) aspirates and biopsy specimens.

Methods

Subjects with a history of a systemic reaction caused by a Hymenoptera sting underwent the standard diagnostic work-up for Hymenoptera allergy, and sBT levels were measured. Subjects with an increased sBT level had BM evaluation that included histology/cytology, flow cytometry, and detection of KIT mutations.

Results

Forty-four (11.6%) of 379 subjects with systemic reactions had increased sBT levels (>11.4 ng/mL), and 31 (70.5%) of these had a history of anaphylaxis. Thirty-four subjects with increased sBT levels underwent a BM analysis. Histology detected diagnostic or subdiagnostic MC infiltrates in 22 (65%) of 34 patients. Abnormal MCs were identified by means of flow cytometry and cytology in 26 (78.8%) of 33 and 20 (58.8%) of 34 subjects, respectively. A KIT mutation was detected in 17 (54.8%) of 31 subjects. The diagnosis was indolent systemic mastocytosis in 21 (61.7%) of 34 subjects and monoclonal MC activation syndrome in 9 (26.5%) of 34 subjects. All subjects with anaphylaxis had one of those 2 disorders.

Conclusion

The concomitant presence of systemic reactions (especially anaphylaxis) after Hymenoptera stings and increased sBT levels strongly suggests that a BM examination is indicated for the diagnosis of clonal MC disease.

Le texte complet de cet article est disponible en PDF.

Key words : Hymenoptera venom allergy, anaphylaxis, serum tryptase, mastocytosis, bone marrow

Abbreviations used : BM, HVA, ISM, MC, MMAS, sBT, SM


Plan


 Supported by European LeukemiaNet, AIL (Associazione Italiana contro le Leucemie-linfomi e mieloma) Verona Onlus, AIRC (Associazione Italiana per la Ricerca sul Cancro), and Fondazione Del Monte di Bologna e Ravenna.
 Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.


© 2009  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 123 - N° 3

P. 680-686 - mars 2009 Retour au numéro
Article précédent Article précédent
  • High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: A randomized, placebo-controlled, crossover study
  • Frank Siebenhaar, Franziska Degener, Torsten Zuberbier, Peter Martus, Marcus Maurer
| Article suivant Article suivant
  • Assessing anaphylactic risk? Consider mast cell clonality
  • Dean D. Metcalfe, Lawrence B. Schwartz

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.